Floxuridine

FDA Approved: * April 6, 2000
Pharm Company: * BEDFORD
Category: Cancer

Floxuridine (also 5-fluorodeoxyuridine) is an oncology drug that belongs to the class known as antimetabolites. Specifically, floxuridine is a pyrimidine analog, classified as a deoxyuridine.[1] The drug is usually administered via an artery, and most often used in the treatment of colorectal cancer. The quality of life and survival rates of individuals that receive continuous hepatic artery infusion of floxuridine for colorectal cancer metastases is significantly higher than ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Floxuridine 100 mg/ml Intra-arterial Injection, Powder, Lyophilized, for Solution

NDC: 0143-9270

Labeler:

West-ward Pharmaceuticals Corp

Floxuridine 500 mg/5ml Intra-arterial Injection, Powder, Lyophilized, for Solution

NDC: 55390-135

Labeler:

Bedford Laboratories

Floxuridine 500 mg/5ml Intra-arterial Injection, Powder, Lyophilized, for Solution

NDC: 63323-145

Labeler:

App Pharmaceuticals, LLC

Floxuridine 500 mg Intra-arterial Injection, Powder, Lyophilized, for Solution

NDC: 81643-9270

Labeler:

Cerona Therapeutics, Inc.

Related Brands

Drugs with the same active ingredients

FUDR